Super-enhancer-dependent transcriptional and m⁶A-mediated post-transcriptional regulation cooperatively drive lncRNA H19 to promote ESCC progression
Cellular Oncology · 2026-12 · 49 (6)
DOI: 10.1007/s13402-026-01278-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 21.08.2026. Verfasst von Zejun Zheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102400, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Super Enhancers, Esophageal Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangdong Medical University Undergraduate Innovation and Entrepreneurship Education Base Project, Guangdong Medical Research Foundation, Natural Science Foundation of Guangdong Province - Outstanding Youth Project.
Abstract (Originalsprache)
BACKGROUND: Epigenetic dysregulation mediated by long non-coding RNAs (lncRNAs), super-enhancers (SEs), and m⁶A modification remains incompletely characterized in esophageal squamous cell carcinoma (ESCC). METHODS: ChIP-qPCR, dual-luciferase reporter assays and CRISPRi were performed to investigate the transcriptional regulation mechanism of H19 by super-enhancer. The functions and downstream signal transduction mechanisms of the H19 in ESCC were explored by a series of in vitro and in vivo assays, including RNA stability, RIP-qPCR, and MeRIP-qPCR. Furthermore, single-cell RNA sequencing (scRNA-seq) and pseudotime trajectory analysis were used to analyze its correlation with ESCC patient survival. RESULTS: We identified H19, a super-enhancer-driven lncRNA, as a critical oncogenic factor in ESCC, with its overexpression significantly correlating with poor patient prognosis. Mechanistically, the master transcription factor KLF5 binds the super-enhancer region of H19 locus to drive its transcriptional activation. Post-transcriptionally, H19 interacts with the m⁶A methylation reader protein IGF2BP2, which stabilizes H19 in an m⁶A-dependent manner mediated by METTL3. The resulting H19/IGF2BP2 complex upregulates the oncogenic Tweety family member 3 (TTYH3) by enhancing mRNA stability. Functional assays revealed that the H19/IGF2BP2-TTYH3 axis facilitates ESCC malignant progression, while the IGF2BP2 inhibitor CWI1-2 suppresses tumorigenesis. ScRNA-seq combined with pseudotime trajectory analysis further established a significant positive correlation between METTL3/IGF2BP2/TTYH3 expression and malignant phenotypes in ESCC. CONCLUSIONS: The H19/IGF2BP2-TTYH3 axis drives ESCC progression, providing valuable prognostic biomarkers and promising therapeutic targets for ESCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102400, China.
- Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dongguan, 523808, P.R. China.
- Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, 515041, China.
- School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102400, China. gaicong9046@163.com.
- School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102400, China. guojincheng@bucm.edu.cn.
Förderung
- Guangdong Medical University Undergraduate Innovation and Entrepreneurship Education Base Project
- Guangdong Medical Research Foundation
- Natural Science Foundation of Guangdong Province - Outstanding Youth Project
- National Natural Science Foundation of China
- National Undergraduate Training Program for Innovation and Entrepreneurship
- Beijing Nova Program
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zheng, Z., Han, D., Zhang, Y., Li, Y., Fan, X., Su, Q., Kang, Z., Sun, J., Chen, Y., Xie, J., Zhang, Z., Gai, C., & Guo, J. (2026). Super-enhancer-dependent transcriptional and m⁶A-mediated post-transcriptional regulation cooperatively drive lncRNA H19 to promote ESCC progression. Cellular Oncology, 49(6). https://doi.org/10.1007/s13402-026-01278-3
Vancouver
Zheng Z, Han D, Zhang Y, Li Y, Fan X, Su Q, et al. Super-enhancer-dependent transcriptional and m⁶A-mediated post-transcriptional regulation cooperatively drive lncRNA H19 to promote ESCC progression. Cellular Oncology. 2026;49(6). doi:10.1007/s13402-026-01278-3
BibTeX
@article{Zheng2026,
author = {Zheng, Zejun and Han, Dongchen and Zhang, Yuying and Li, Yanshang and Fan, Xuan and Su, Qixin and Kang, Zhuoying and Sun, Jingming and Chen, Yiqing and Xie, Jianjun and Zhang, Zhixuan and Gai, Cong and Guo, Jincheng},
title = {Super-enhancer-dependent transcriptional and m⁶A-mediated post-transcriptional regulation cooperatively drive lncRNA H19 to promote ESCC progression},
journal = {Cellular Oncology},
year = {2026},
volume = {49},
number = {6},
doi = {10.1007/s13402-026-01278-3}
}
EUVIMED